Prescription and nonprescription drug use in isfahan, Iran: An observational, cross-sectional study

Current Therapeutic Research - Clinical and Experimental

Volumn 69, Issue 1, 2008, Pages 76-87

  Zargarzadeh, Amir H ^a   Minaeiyan, Mohsen ^a   Torabi, Amir ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Imam Jafar Sadegh Hospital   (Iran)

Author keywords

drugs; Iran; nonprescription; over the counter; self medication

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; CARDIOVASCULAR AGENT; DERMATOLOGICAL AGENT; GASTROINTESTINAL AGENT; HERBACEOUS AGENT; IMMUNOMODULATING AGENT; NANDROLONE PHENPROPIONATE; NON PRESCRIPTION DRUG; RESPIRATORY TRACT AGENT; SEX HORMONE; URINARY TRACT AGENT;

ADOLESCENT; ADULT; ARTICLE; CLUSTER ANALYSIS; DRUG LEGISLATION; DRUG USE; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SELF MEDICATION;

EID: 41249084915     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2008.02.002     Document Type: Article

References (27)

1. Non prescription drug sales in Iran. Ministry of Health and Medical Education Report (2004), Tehran, Iran
2. Scherer F. The pharmaceutical industry-prices and progress. N Engl J Ned 351 (2004) 927-932
3. Brass E. Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med 345 (2001) 810-816
4. Donjon R., and Goeckner B. Mosby's OTC Drugs: An over-the-counter drug resource for health professionals (1999), Mosby Inc, Chicago, Ill 1
5. Aronson J. Over-the-counter medicines. Br J Clin Pharmacol 58 (2004) 231-234
6. Pray W., and Pray J. How medications gain FDA-approved OTC status. US Pharmacist 28 (2003) 10
7. Bond C., and Hannaford P. Issues related to monitoring the safety of over-the-counter (OTC) medicines. Drug Saf 26 (2003) 1065-1074
8. US Food and Drug Administration FDA News. FDA enhances safeguards for consumers who may have special sensitivities to certain commonly used over-the-counter drug ingredients.
9. http://www.fda.gov/bbs/topics/news/2OOd/NEWOlOdl.html Accessed November 15, 2006
10. Reyndds T. Switching from prescription to over the counter. Ann Intern Med 136 (2002) 177-180
11. In: Berardi R., DeSimone E., Newton G., et al. (Eds). Handbook of Nonprescription Drugs. 13th ed (2002), APhA Publications, Washington, DC 5
12. Carlsten A., Wennberg M., and Bergendal L. The influence of Rx-to-OTC changes on drug sales. Experiences from Sweden 1980-1994. J Clin Pharm Ther 21 (1996) 423-430
13. List of non-prescription medications. Ministry of Health and Medical Education Report (2002), Tehran, Iran
14. List of non-prescription medications. Ministry of Health and Medical Education Report (2004), Tehran, Iran
15. Awad A., Eltayeb I., Matowe L., and Thalib L. Self-medication with antibiotics and antimalarials in the community of Khartoum State, Sudan. J Pharm Pharm Sci 8 2 (2005) 326-331
16. Chang F., and Trivedi P. Economics of self-medication: Theory and evidence. Health Econ 12 (2003) 721-739
17. World Health Organization. WHO guidelines for the regulatory assessment of medicinal products for use in self-medication. WHO Drug Inform 14 (2001) 18-26
18. Berzanskyte A., Valinteliene R., Haaijer-Ruskamp F., et al. Self-medication with antibiotics in Lithuania. Int J Occup Med Environ Health 19 (2006) 246-253
19. Grigoryan L., Burgerhof J., Haaijer-Ruskamp F., et al., for the SAR Group. Is self-medication with antibiotics in Europe driven by prescribed use?. J Antimicrob Chemother 59 (2007) 152-156
20. List of non-prescription medication. Ministry of Health and Medical Education Report (1998), Tehran, Iran
21. World Health Organization. Guidelines for ATC Classification and DDD Assignment. 5th ed (2002), World Health Organization, Oslo, Norway
22. Siahi-shadbad MR, Garjani AR, Saif-barghi A, Maleki N; A survey on knowledge base of patients requesting non prescription drugs in Ardabil City. Presented at: 8th Iranian Seminar of Pharmaceutical Sciences; August 27-29, 2002; Shiraz, Iran.
23. Iranian pharmaceutical profile. Ministry of Health and Medical Education Report (2002), Tehran, Iran
24. Fleming G., McElnay J., and Hughes C. Development of a community pharmacy-based model to identify and treat OTC drug abuse/misuse: A pilot study. Pharm World Sci 26 (2004) 282-288
25. Fenichel R. Which drugs should be available over the counter?. BMJ 329 (2004) 182-183
26. Otto A. Interest revives in 'behind-the-counter' drugs. Pharmacy Today (2000) 6
27. Whitehill D. OTC drugs: Categories I, II, and III. S D J Med 56 (2003) 221-222